Triguero-Martínez, Ana
de la Fuente, Hortensia
Montes, Nuria
Ortiz, Ana María
Roy-Vallejo, Emilia
Castañeda, Santos
González-Alvaro, Isidoro
Lamana, Amalia
Funding for this research was provided by:
Comunidad de Madrid (PEJD-2019-PRE/BMD-16851)
Instituto de Salud Carlos III (RD16/0011/0012, CM19/00149, PI12/01578, PI18/0371)
Article History
Received: 15 June 2020
Accepted: 21 September 2020
First Online: 20 October 2020
Competing interests
: IG-A reports grants from Instituto de Salud Carlos III, during the course of the study; personal fees from Lilly and Sanofi; personal fees and non-financial support from BMS; personal fees and non-financial support from Abbvie; research support, personal fees and non-financial support from Roche Laboratories; non-financial support from MSD, Pfizer and Novartis, not related to the submitted work.SC has received personal fees from Amgen, Lilly, MSD, Pfizer, Roche, Sanofi and SOBI. SC is also assistant professor of the cátedra UAM-Roche, EPID-Future, Universidad Autónoma de Madrid (UAM).The remaining authors report no competing interests with the submitted work.